Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Pharmather Holdings Ltd PHRRF


Primary Symbol: C.PHRM

PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The... see more

Bullboard (CSE:PHRM)

View:
Post by moneywagonon Mar 31, 2022 12:42pm

PHRM 3 MILL BULLS BID @14~SP SCREECHING GRINDING FROM @$1.24

sorrrry OOOPS my capital shift button didn't hit the MONEY MONEY SIGN SORRY
Post by moneywagonon Mar 31, 2022 12:41pm

PHRM 3 MILL BULLS BID @14~SP SCREECHING GRINDING FROM @41.24

ALMOST 3 MILLION bulls want your shares!  Good Lord if anybody moves a hair in that Bull BID line up....... the sp is going to split at the seams OR POP POP POP like a pin pri@K to a balloon! LOL
Post by Iamjaygeeon Mar 30, 2022 4:04pm

Was hoping for more volume today

Today was a pain getting my orders filled. Lol Maybe tomorrow...
Post by moneywagonon Mar 30, 2022 12:49pm

PHRM TOMORROW LAST DAY FOR SHORTS BI SESSION

Share price might see a power hour after lunch! Absolutely oversold!!
Post by moneywagonon Mar 30, 2022 12:09pm

PHRM SO 52WK HIGH WAS $1.24? HAVE I GOT THAT RIGHT?

ALERT signal brought me this way...whats up ? money ahhaah heck everybody needs money . No seriously what happened here?
Comment by Iamjaygeeon Mar 28, 2022 5:35pm

RE:WHAT WAS WRONG WITH THE RESULTS AND NEWS RELEASE?

They're running out of cash It's as simple as that.
Post by Predator2018on Mar 28, 2022 2:27pm

WHAT WAS WRONG WITH THE RESULTS AND NEWS RELEASE?

JUST WONDERING WHY THE MASSIVE SELLOFF ON THE RESULTS NEWS
Post by GeneralWolfeon Mar 25, 2022 10:23am

Get in while you can...

dirt cheap....thank you
Comment by GustheGreekon Mar 23, 2022 4:59pm

RE:PharmaTher Announces Positive Topline Results

Lol, good news (sort of), and it lost more than a third of its value. SHORTS, SHORTS, AND MORE SHORTS! Imo, it's time to jump back in this one.
Post by Betteryear2on Mar 23, 2022 7:48am

PharmaTher Announces Positive Topline Results

100% of patients treated with ketamine demonstrated reduction in dyskinesias as measured by the Unified Dyskinesia Rating Scale Ketamine was well tolerated with no serious adverse events reported ...more  
Post by Betteryear2on Feb 16, 2022 6:58pm

Grant of U.S. Patent on Ketamine Formulation

TORONTO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a leader in specialty ketamine pharmaceuticals, is pleased to announce ...more  
Post by Betteryear2on Jan 04, 2022 7:27am

Publication of Research Data for KETABET™

Second published study to demonstrate the potential therapeutic utility and mechanism of action of KETABET™ (patented combination of ketamine and betaine) in models of depression Repeated use of ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities